SCHEMBL16769909

SCHEMBL16769909

CCc1ccc(/C=C2\CN(CC)C/C(=C\c3ccc(CC)cc3)C2=O)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.62
ALDH1A1 P00352 6/20 0.62
LMNA P02545 5/20 0.62
KMT2A Q03164 4/20 0.62
MEN1 O00255 3/20 0.62
POLB P06746 1/20 0.62
HTT P42858 4/20 0.56
SMN1; SMN2 Q16637 4/20 0.56
NPC1 O15118 3/20 0.56
RAB9A P51151 3/20 0.56
GAA P10253 2/20 0.56
ATM Q13315 2/20 0.56
MDM4 O15151 1/20 0.56
JAK2 O60674 1/20 0.56
XBP1 P17861 1/20 0.56
MDM2 Q00987 1/20 0.56
DRD3 P35462 1/20 0.54
MAPK1 P28482 3/20 0.52
HSP90AA1 P07900 2/20 0.52
NPSR1 Q6W5P4 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15562267 1.00 MAPT (0.62) MAPTALDH1A1LMNAKMT2AMEN1
SCHEMBL15562265 1.00 MAPT (0.62) MAPTALDH1A1LMNAKMT2AMEN1
SCHEMBL19840315 0.90 MAPT (0.65) MAPTALDH1A1LMNAKMT2AMEN1
SCHEMBL16769897 0.88 MAPT (0.59) MAPTALDH1A1LMNAKMT2AMEN1
SCHEMBL15562520 0.88 MAPT (0.59) MAPTALDH1A1LMNAKMT2AMEN1
SCHEMBL15562519 0.88 MAPT (0.59) MAPTALDH1A1LMNAKMT2AMEN1
SCHEMBL16769901 0.85 MAPT (0.63) MAPTALDH1A1LMNAKMT2AMEN1
SCHEMBL31518776 0.85 ACHE (0.61) MAPTALDH1A1LMNAKMT2AMEN1
SCHEMBL16755572 0.85 MAPT (0.63) MAPTALDH1A1LMNAKMT2AMEN1
SCHEMBL16755571 0.85 MAPT (0.63) MAPTALDH1A1LMNAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9884825-B2 Curcumin analogs and methods of making and using thereof GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2018-02-06 US disclosed
US-9884825-B2 Curcumin analogs and methods of making and using thereof GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2018-02-06 US disclosed
US-20150152056-A1 Curcumin Analogs and Methods of Making and Using Thereof UNIVERSITY OF DELHI (IN) 2015-06-04 US disclosed
US-20150152056-A1 Curcumin Analogs and Methods of Making and Using Thereof UNIVERSITY OF DELHI (IN) 2015-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150152056-A1 Curcumin Analogs and Methods of Making and Using Thereof COX15, HCCS, HMOX2 MAPT 3159/4885ALDH1A1 94/4885LMNA 515/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.